(Q35884885)

10 August 2017

1 reference

title

AEDs and psychotropic drugs in children with autism and epilepsy (English)

1 reference

10 August 2017

0 references

1 reference

Roberto Tuchman

1

1 reference

10 August 2017

publication date

1 January 2004

1 reference

Mental Retardation and Developmental Disabilities Research Reviews

10 August 2017

published in

1 reference

10 August 2017

volume

10

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

135-138

1 reference

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20026

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20026

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20026

Pervasive developmental disorder and epilepsy due to maternally derived duplication of 15q11-q13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20026

Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20026

Clinical and neurochemical effects of fenfluramine in children with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20026

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20026

Autism: electroencephalogram abnormalities and clinical improvement with valproic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20026

Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20026

21 January 2018

Identifiers

DOI

10.1002/MRDD.20026

1 reference

10 August 2017

1 reference